News ‘Smart’ pillbox wins Takeda depression challenge EllieGrid improves medication adherence by reminding patients when to take medicines.
News Takeda earmarks $15 billion for M&A - reports Japanese company could be on the acquisition trail.
News Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out More CDF legacy products likely to face same fate
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.